Phase I trial of EBC C12 +/- EBS A42

Trial Profile

Phase I trial of EBC C12 +/- EBS A42

Discontinued
Phase of Trial: Phase I

Latest Information Update: 01 Dec 2011

At a glance

  • Drugs Streptococcal B vaccine (Primary) ; EBS A42; EBS C12
  • Indications Streptococcal infections
  • Focus Adverse reactions
  • Sponsors Emergent BioSolutions
  • Most Recent Events

    • 01 Dec 2011 Status changed from planning to discontinued prior to enrolment (development of vaccine discontinued).
    • 27 Dec 2006 The expected completion date for this trial is now 1 Dec 2008.
    • 27 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top